Skip to content

Comparison of findings among thyroid scintigraphy, FDG PET/CT and FLT PET/CT in thyroid cancer

Comparison of findings among thyroid scintigraphy, FDG PET/CT and FLT PET/CT in thyroid cancer - Comparison of findings among thyroid scintigraphy, FDG PET/CT and FLT PET/CT in thyroid cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000005278
Enrollment
60
Registered
2011-03-18
Start date
2011-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid cncer

Interventions

Scans start one day after oral administration of I-123 or three days after oral administration of I-131. FDG PET/CT image acquisition start 1 hour after intravenous administration of FDG. FLT PET/CT

Sponsors

Kagoshima University Hospital. Department of Radiology
Lead Sponsor
Department of Radiology, Nanpuh hospital
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patients with thyroid cancer who are evaluated about staging before and after therapy.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Thyroid scintigraphy (I-123 or I-131 scintigraphy), FLT and FDG-PET/CT images are visually evaluated and semiquantitatively by calculating the maximum standardized uptake value (SUVmax).

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026